The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Pharm2Farm has launched a new high alcohol based medical grade hand sanitizer.
https://www.pharm2farm.org/ntu-nanoparticle-spin-out-launches-new-hand-sanitizer-to-help-with-covid-19-outbreak/
I topped up yesterday on the basis of another solid report on income and debt repayment. This is a nicely boring, dividend paying metals play and there aren't many like it on AIM. One to hold long term for me.
I agree let's not get our hopes up too high here. The share buyback is welcome and may nudge the share price back towards 2p as it rolls out. But for me the main trigger which would propel it higher has already gone - eg the sale of MOD to SFR. I see the main hope of a real rise would be the proving up of KML copper grades and Sandfire then making a bid for the KML asset - or even an acquisition of MTR. This would consolidate their ownership of a large copper block in Botswana, tidy up their shareholding and give them MTR's London base and an expert team to look at future investments. But this is pretty speculative and I don't see it happening soon.
So the MOD sale has happened and we now have a liquid asset in Sandfire stock. And the promise of dividends and net smelter royalty down the line. All supposedly trigger events to move the share price back up to or above NAV. But it hasn't happened and we are still at 1.25p as at today. If the value of MTR isn't recognised now, when will it be ?
Another "iron in the fire" for Arix. It looks a promising field to invest in.
STipe’s technology can increase the sensitivity of the immune system to detect even a small amount of tumour-DNA. This opens up the potential to induce an immune response alone or in combination with targeted anticancer therapies, immunotherapy or radiation.
"There is a glaring disconnect between the stock market’s miserly valuation of Kape Technologies and the operational performance of the company."
https://www.investorschronicle.co.uk/comment/2019/09/18/exploit-kape-s-valuation-anomaly/
“We’ve invested 7.7 million pounds into MOD Resources and the recent takeover offer from Sandfire Resources would place our value at about 25 million pounds”, says McNeilly. But the share price still isn't moving up. This is testing my patience...
Hi all. I have been watching Arix since May and think 130p is a good entry price so have made my first purchase in my SIPP.
Their investment portfolio looks promising, cash position is strong and broker sentiment is positive. One to hold and watch...
https://www.proactiveinvestors.com/companies/news/219791/arix-biosciences---venture-capital-firm-flies-under-the-market-s-radar-219791.html
One concern: Having sold most of their fund management business, do BRH have sufficient cash generation from the remaining bit to fund their operating costs and continue investing in their incubator businesses ? I don't have the forensic accounting skills to compare income to their cash burn, but would be interested in views on this from others.. thanks.
Thanks for posting this Burton. It's a good summary on BRH with a positive conclusion - which I agree with:
"Braveheart offers a unique proposition on AIM given that it is an investment company that is self-funding and has a good level of cash. The investments offer exposure to a variety of different sectors and are each at meaningful enough levels that should any one or more strike gold then Braveheart shareholders will reap a significant benefit."
I see this as a good buying opportunity and believe that there will be support at around the 2p mark. I could be wrong, but have backed my judgement with a £10k top up for another 514,138 shares this morning. Best of luck to all long term investors in MTR. Roll on the feasibilty study next spring.
Dividend banked but share price going nowhere at the moment. I'll continue to hold on the basis that CML is cash-generative, has no borrowings and dividend paying. So some defensive merits
Summary of Interim statement on 1st August:
Revenue, operational costs and profitability for the opening months of the financial year marginally ahead of expectations.
Issues around raw material lead times and customer purchasing patterns impeded performance in some areas.
New products to be launched shortly, adding to future revenue streams.
Full year outlook remains unchanged
Encouraging to see the share price holding up well despite going ex dividend. Final dividend of 5.8p will be paid on 6 August with an ex-dividend date of 5 July 2018. I'm selling out some of the tech stocks in my portfolio, but CML are a keeper for the moment based on the yield and steady growth. Full year results announced in June were solid:
Group revenues increased 14% to £31.67m
Gross profit up 12% to £22.24m
Profit before tax up 9% to £4.58m
Basic EPS up 6% to 24.52p
Total cash balances were a record £13.82m
Interesting company. Wish I had come across it earlier. Cyberghost looks a great acquisition. Good growth prospects, solid EBITDA, strong cash position, potential for a game-changing acquisition. And no manic rampers on the BB :-) On my watch list - now I just need to find a good entry price....
Another £5k top up for me this morning. IMHO this will bottom out shortly and begin to move up again. Worth 10 mins to watch this video of the CAML Chairman Nick Clarke covering their 2017 results and future plans. Sensible bloke, with a cautious attitude to risk and a positive approach to paying dividends. CAML appear to be a well managed, low risk producer and now diversified into Zinc and Lead following the SASA acquisition. And Kounrad continues to produce copper at 50 cents per lb which they sell at $3 per lb. Bodes well for future dividends.. GLA and I will hold with confidence. https://www.youtube.com/watch?time_continue=423&v=aXqlMD9enJ8
Profitable, dividend paying, low cost copper producer. While the global supply / demand imbalance is pushing up copper price month by month. What's not to like ? Another £5k top up for me this morning to buy in the dip.
Agree that Kirkstall could turn out to be a very profitable investment for BRH. Will be interesting to see what impact the new distribution agreement with Lonza has on sales and I hope this will be covered in the results announcement. I had a look at the testimonial videos on Quasi Vivo and it seems to be a popular and easy to use tool set for researchers. http://www.kirkstall.com/why-quasi-vivo2/
Looks a smart move to me as it gives Metal Tiger exposure to a further 4,063 km2 of unexplored ground. Take a look at the map - this is adjacent to Cupric Canyon and north of the current MOD/MTR concession area. http://kalaharimetals.com/botswana-project-overview/ Metal Tiger will have the right to acquire up to 50% of KML for a total consideration of US$1.6 million. First option has been exercised for 18% of KML�s share capital for US$600,000 2 further options available over next 12 months to take the MTR holding to 50% - for a further $1m investment. KML have the right to earn-in to up to 80% of Triprop followed by a right to purchase the remaining 20% of Triprop.